TIMOTHY LEDERER: Open Payments
NPI 1033695960 · PARKVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,659 in 116 payments from 30 companies in 2025. Trend: 2023 $559 · 2024 $2,196 · 2025 $2,659
Food & beverage: $2,659
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $311 |
| Novo Nordisk Inc | 13 | $280 |
| ABBVIE INC. | 16 | $280 |
| Lundbeck LLC | 7 | $174 |
| Janssen Pharmaceuticals, Inc | 3 | $174 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $160 |
| Lilly USA, LLC | 10 | $146 |
| PFIZER INC. | 8 | $135 |
| Exact Sciences Corporation | 4 | $92 |
| Amgen Inc. | 4 | $75 |
Products named: REXULTI, AIRSUPRA, Ozempic, SPRAVATO, Kerendia, QULIPTA, VRAYLAR, MOUNJARO.
Industry payments across MD — which companies pay providers there.
